These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21501597)

  • 61. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
    Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
    Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure.
    Park H; Hwang KY; Oh KH; Kim YH; Lee JY; Kim K
    Bioorg Med Chem; 2008 Jan; 16(1):284-92. PubMed ID: 17920282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.
    Luksch T; Chan NS; Brass S; Sotriffer CA; Klebe G; Diederich WE
    ChemMedChem; 2008 Sep; 3(9):1323-36. PubMed ID: 18752222
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery of potent inhibitors of pseudomonal quorum sensing via pharmacophore modeling and in silico screening.
    Taha MO; Al-Bakri AG; Zalloum WA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5902-6. PubMed ID: 16945524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2250-5. PubMed ID: 18358718
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Small molecule inhibitors of E. coli primase, a novel bacterial target.
    Agarwal A; Louise-May S; Thanassi JA; Podos SD; Cheng J; Thoma C; Liu C; Wiles JA; Nelson DM; Phadke AS; Bradbury BJ; Deshpande MS; Pucci MJ
    Bioorg Med Chem Lett; 2007 May; 17(10):2807-10. PubMed ID: 17350255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
    Gautam A; Rishi P; Tewari R
    Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Virtual high throughput screening of carbapenem derivatives as new generation carbapenemase and penicillin binding protein inhibitors: a hunt to save drug of last resort.
    Chowdhury A; Paul P; Bhattacharjee A; Talukdar AD; Choudhury MD
    Comb Chem High Throughput Screen; 2015; 18(1):18-23. PubMed ID: 25542226
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.
    Ko S; Lee MK; Shin D; Park H
    Bioorg Med Chem; 2009 Nov; 17(22):7769-74. PubMed ID: 19822432
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of novel pneumococcal surface antigen A (PsaA) inhibitors using a fragment-based drug design approach.
    Bajaj M; Mamidyala SK; Zuegg J; Begg SL; Ween MP; Luo Z; Huang JX; McEwan AG; Kobe B; Paton JC; McDevitt CA; Cooper MA
    ACS Chem Biol; 2015 Jun; 10(6):1511-20. PubMed ID: 25786639
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin).
    Carson L; Cathcart GR; Scott CJ; Hollenberg MD; Walker B; Ceri H; Gilmore BF
    Biochimie; 2011 Oct; 93(10):1824-7. PubMed ID: 21762758
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Zinc-selective inhibition of the promiscuous bacterial amide-hydrolase DapE: implications of metal heterogeneity for evolution and antibiotic drug design.
    Uda NR; Upert G; Angelici G; Nicolet S; Schmidt T; Schwede T; Creus M
    Metallomics; 2014 Jan; 6(1):88-95. PubMed ID: 24057071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Streptococcus mutans SMU.623c codes for a functional, metal-dependent polysaccharide deacetylase that modulates interactions with salivary agglutinin.
    Deng DM; Urch JE; ten Cate JM; Rao VA; van Aalten DM; Crielaard W
    J Bacteriol; 2009 Jan; 191(1):394-402. PubMed ID: 18978064
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
    Piizzi G; Parker DT; Peng Y; Dobler M; Patnaik A; Wattanasin S; Liu E; Lenoir F; Nunez J; Kerrigan J; McKenney D; Osborne C; Yu D; Lanieri L; Bojkovic J; Dzink-Fox J; Lilly MD; Sprague ER; Lu Y; Wang H; Ranjitkar S; Xie L; Wang B; Glick M; Hamann LG; Tommasi R; Yang X; Dean CR
    J Med Chem; 2017 Jun; 60(12):5002-5014. PubMed ID: 28549219
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polysaccharide deacetylases serve as new targets for the design of inhibitors against Bacillus anthracis and Bacillus cereus.
    Balomenou S; Koutsioulis D; Tomatsidou A; Tzanodaskalaki M; Petratos K; Bouriotis V
    Bioorg Med Chem; 2018 Jul; 26(13):3845-3851. PubMed ID: 29983281
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents.
    Smith RP; Paxman JJ; Scanlon MJ; Heras B
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438817
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of the first known inhibitors of O-acetylpeptidoglycan esterase: a potential new antibacterial target.
    Pfeffer JM; Clarke AJ
    Chembiochem; 2012 Mar; 13(5):722-31. PubMed ID: 22351512
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Group A streptococcus inhibitors by high-throughput virtual screening.
    Hu H; Mao S; Bugrysheva JV; Pruett S; Liotta DC; Scott JR; Snyder JP
    Eur J Med Chem; 2014 Jul; 82():120-6. PubMed ID: 24880231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.